CytoSorbents Corporation - CTSO Company Value to Revenue Ratio

Public company logo of CytoSorbents Corp. (CTSO)

Cytosorbents (CTSO) leads the blood purification systems segment, expanding its presence in cardiac surgery. The price-to-sales multiple dynamics on the GURU.Markets daily chart confirm this trend, where the value of 1131.61 expresses the metric level. Growth is driven by automated cartridges with digital control, while strict patents and complex certification requirements in the EU and US guarantee business stability.

CTSO CytoSorbents Corporation: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

CTSO (cytosorbents.com): analytical breakdowns and indicator data

Fundamental valuation:CytoSorbents Corp CTSO
Mass-produced product of Cytosorbents

This indicator reflects the ratio of enterprise value to revenue, excluding the impact of debt load to provide an objective assessment of the asset's market value. In the context of Cytosorbents (CTSO), the ratio of enterprise value to annual revenue is critically important, as high capital expenditure and regulatory complexities with the FDA could lead to a company revaluation in the event of a liquidity shortage.

Competitor analysis for Cytosorbents

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|Inspire Sleep (INSP) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple PRCT|Company Value to Revenue CONMED Corporation CNMD|EV/Sales Multiple PLSE (pulsebiosciences.com)|EV/Sales Multiple InMode Ltd INMD|PMI: Company Value to Revenue|SRDX: Enterprise Value-to-Revenue Ratio|SENS (Senseonics Corp) - Company Value to Revenue|NeuroPace, Inc. - Business Value to Revenue|TCMD (Tactile Systems Technology, Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SANUWAVE Health SNWV|EV/Sales Multiple OM|Electromed Inc (ELMD) - Enterprise Value-to-Sales Ratio|LENSAR Inc - Company Value to Revenue|EV/Sales Multiple AVITA Medical, Inc. RCEL|Profound Medical Corp - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Baird Medical BDMD|EDAP TMS (EDAP) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume APYX (Bovie Medical)|Enterprise Value-to-Revenue Ratio icecure-medical.com|Company Value to Revenue Pulmonx Corporation (LUNG)|EV/Sales Multiple TELA|SRTS - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Zynex, Inc. ZYXI|ECOR: Company Value to Revenue Ratio|RBOT: Company Value to Revenue|inspira-technologies.com - Enterprise Value-to-Revenue Coefficient|ICU: EV/Sales Multiple|IRIX - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Intelligent Bio Solutions Inc.|Enterprise Value-to-Revenue Multiple Beyond Air XAIR|Enterprise Value-to-Revenue Ratio Profusa Inc. (PFSA)|SSKN (STRATA Skin Sciences, Inc.) - Business Value to Revenue|EV/Sales Multiple GCTK (GlucoTrack Inc.)|NanoVibronix, Inc. (NAOV) - Enterprise Value-to-Revenue Multiple|VERO - Enterprise Value-to-Revenue Ratio|NUWE: Enterprise Value-to-Revenue Ratio|Aethlon Medical Inc (AEMD) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)